ABT Abbott Laboratories

$-1.69 (-1.54%)

ABT Stock Analysis Overview

What this means: Abbott Laboratories (ABT) gets an Overall Rank of 74, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ABT's 74 means that it ranks higher than 74% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Abbott Laboratories (ABT) Analyst Forecast

Next 12 months ➝MEAN$113.50+5.30%HIGH$125.00+15.97%LOW$102.00-5.37%Current Price$107.7952-week High$114.1952-week Low$61.61
  • Last Price$107.79
  • Previous Close$109.48
  • Change $-1.69
  • Open$109.64
  • Volume3,395,661
  • Avg. Volume (100-day)5,392,497
  • Market Capitalization$191B
  • Days Range $107.57 - $110.00
  • 52-week Range $61.61 - $114.19
  • Dividend Yield1.31%
  • Ex. Dividend Date10/14/2020
  • P-E57.9
  • EPS1.89
  • Earnings Date01/19/2021
  • SectorHealthcare
  • IndustryMedical Devices
  • Avg. Analyst Rec.
  • Beta1.221
  • PEG Ratio2.99
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.